S&P Global Sustainability Yearbook 2024: Sun Pharma Inclusion

Sun Pharmaceutical Industries Limited has announced its inclusion in the SandP Global Sustainability Yearbook 2024. This yearbook aims to identify companies in each industry that have demonstrated a commitment to corporate sustainability.

This recognition demonstrates Sun Pharma's commitment to incorporating environmental, social and governance (ESG) principles through initiatives focused on its businesses.

Dilip Shanghvi, CEO of the company, said, "Sun Pharma is always focused on providing sustainable products for all stakeholders. Sustainability is an important part of doing business. We follow a clear roadmap of ESG priorities, and our inclusion in the SandP Yearbook reflects our progress on that roadmap.”

More than 9,400 companies were assessed in the 2024 Sustainability Yearbook, based on the SandP Global Corporate Sustainability Assessment of 2023. (CSA). Of these, 739 global companies have qualified for inclusion in the 2024 Sustainability Yearbook.

Sun Pharma is the world's fourth-largest global company engaged in specialty healthcare products, vaccines and healthcare products. It is India's largest pharmaceutical company and a leading biotechnology company, not only in the United States but also in the markets of the modern world.